ClinicalTrials.gg
Sign In

Hyperlipoproteinemia Type I clinical trials

The registry lists 21 studies for Hyperlipoproteinemia Type I across more than 10 countries. 3 are recruiting or about to start. 18 of them are mainly about Hyperlipoproteinemia Type I (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-05.

Get an email when these change. Save the Hyperlipoproteinemia Type I studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
11
Withdrawn
2
Status unknown
2
Recruiting
2
No longer available
1
Approved for marketing
1

Phase

Phase 2
7
Phase 3
4
Phase 1
2
Early Phase 1
1

Where

Canada
12
United States
6
Germany
4
France
2
Israel
2
Australia
2

Who runs them

Amsterdam Molecular Therapeutics (4) · Akcea Therapeutics (3) · Arrowhead Pharmaceuticals (3) · UniQure Biopharma B.V. (2) · University of Texas Southwestern Medical Center (1) · CENTOGENE GmbH Rostock (1) · Shanghai Jiao Tong University School of Medicine (1) · Ionis Pharmaceuticals, Inc. (1)

What is being tested here

Drugs under test in Hyperlipoproteinemia Type I studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Heparin101
CS-121101
Plozasiran012
Mycophenolic Acid022
Cyclosporine022
Orlistat001
ISIS 304801011
Vupanorsen001
Pradigastat001
CAT-2003001

Coming up

0phase 3 studies under way
2studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 2

Who these studies take

Of the 2 Hyperlipoproteinemia Type I studies recruiting now, 0 (0%) set no upper age limit and 2 (100%) stop at 75 or younger. 1 (50%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (50%) take healthy volunteers.

Recruiting studies that take each age, of 2
AgeWomenMen
101 (50%)1 (50%)
182 (100%)2 (100%)
301 (50%)1 (50%)
401 (50%)1 (50%)
501 (50%)1 (50%)
651 (50%)1 (50%)
751 (50%)1 (50%)
850 (0%)0 (0%)

Across all 21 studies, recruiting or not: 48% stop at 75 or younger and 19% at 65; 29% take children; 0% are for women only and 0% for men only; 29% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. search them.